Chinese biologist Han Chunyu has provided his experimental data to Nature as requested to help peer researchers replicate his work, but the controversy has not gone away, according to the journal's website.

Meanwhile Han has been working to replicate his own work.

The incident now is evolving into battle between the widely recognized gene editing tool CRISPR — Cas9 and a potentially better substitute called NgAgo, presented by Han, a geneticist at Hebei University of Science and Technology.

Three months ago, Han reported that the enzyme NgAgo can be used to edit human genes, and an article was published in Nature Biotechnology. However, some researchers said they had been unable to replicate Han's work.

The journal, in response, initiated an investigation and asked Han last week to submit his experimental protocols and original data. The investigation is still underway.

One of the protocols warned that the magnesium level in cells needed to be maintained.

Gaetan Burgio, a geneticist at Australian National University in Canberra, told Nature there was little new in the protocol Han shared.

"That doesn't make any sense to me," he said. Burgio reported on his blog that he had failed to replicate Han's results, which further pushed the controversy into worldwide spotlight.

A Chinese biology researcher in Beijing who asked for anonymity told China Daily that Han's updating of his protocol is a good start.

"Science and research is hard and takes time. We should allow for more time and patience," the researcher said.

Lluis Montoliu, a geneticist at the Spanish National Centre for Biotechnology in Madrid, previously recommended in an e-mail to colleagues at the International Society for Transgenic Technologies that any project involving the use of NgAgo for gene editing should be abandoned.

It's to "avoid wasting time, money, animals and people", the e-mail said.

The Beijing researcher, however, said efforts to push science ahead should never stop. "It's still too early to give a death sentence to NgAgo," the researcher said.

NgAgo, a new approach to gene editing, was touted as being more precise than the mainstream CRISPR — Cas9 approach. CRISPR uses small genetic sequences to guide an enzyme to cut DNA at a particular location, but it sometimes cuts the wrong genes. NgAgo allegedly had no such off-target problems.

Han is known for focusing on his research and maintaining a low-key lifestyle. The article about him on Nature's website said he didn't like to travel, and a trip to visit a collaborator in Hangzhou in March was the first time the 42-year-old had ever boarded a plane.

Contact the writer at shanjuan@chinadaily.com.cn